Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Refractory C-Difficile Infection
NCT02112279Phase 1Unknown
- Start
- Apr 2014
- Primary completion
- Jun 2015
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fecal microbiome transplant in Clostridioides difficile infection (CDI). Primary endpoint: Negative C. difficile test at 30 days. Status: unknown.
02
Drugs
fecal microbiome transplant
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT02112279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02112279.